—

Galenica Sante AG (GALE.SW) — the peer cohort

As of 2026-11-17 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.

Galenica Sante AG ranks 9 of 9 in its cohort on the Closelooknet composite (48/100) — the cohort is led by Halozyme Therapeutics Inc at 71/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
GALE.SW Galenica Sante AG 48 68 31 60 info 10%
BION.SW BB Biotech AG 60 75 95 72 ok 5.1%
SOON.SW Sonova H Ag 59 94 74 45 bull 1.7%
YPSN.SW Ypsomed Holding AG 56 85 62 23 ok 3.6%
BANB.SW Bachem Holding AG 50 67 42 32 info 10.4%
HALO Halozyme Therapeutics Inc 71 67 94 49 info 28.4%
ONC BeOne Medicines AG 66 89 68 29 ok 2.7%
REGN Regeneron Pharmaceuticals Inc 65 90 73 47 neutral 4%
ANN.AU Ansell Ltd 64 97 47 50 ok 1.5%

Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-11-17

Quick answers

Who are Galenica Sante AG's peers in the Closelooknet universe?

The cohort is drawn from shared Closelooknet index membership first, then sector: BB Biotech AG (BION.SW), Sonova H Ag (SOON.SW), Ypsomed Holding AG (YPSN.SW), Bachem Holding AG (BANB.SW), Halozyme Therapeutics Inc (HALO), BeOne Medicines AG (ONC), Regeneron Pharmaceuticals Inc (REGN), Ansell Ltd (ANN.AU), as of 2026-11-17.

How does GALE.SW score against its peers?

Galenica Sante AG's composite reads 48/100, ranking 9 of 9 in its cohort as of 2026-11-17; the cohort's highest composite is Halozyme Therapeutics Inc at 71/100. Closelooknet scores are research diary readings, not ratings or advice.

Related in the Closelooknet universe

then Medical Distribution, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.